Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion.
December 04, 2019
Share
Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. (KOSDAQ:A047920) from DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:A067080) and Wanjoo Kim for KRW 20.2 billion on November 29, 2019. DAE HWA Pharmaceutical sold 1.45 million shares and Wanjoo Kim sold 0.48 million shares for KRW 10,500, respectively. Post completion, DAE HWA Pharmaceutical and Wanjoo Kim do not hold any stake in C-TRI.
Mediforum Co.,Ltd. completed the acquisition of 13.9% stake in C-TRI Co., Ltd. (KOSDAQ:A047920) from DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:A067080) and Wanjoo Kim on November 29, 2019.
DAE HWA PHARM CO.,LTD. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include skeletal muscle relaxants, gastro-intestinal drugs, corticosteroids, antihistamines, cardiovascular drugs, drugs for liver diseases, vitamins, tonics, antibiotics, injections, topical drugs, anti-inflammatory enzymes, analgesics, antipyretics, plaster, cough suppressants, expectorants and mucolytics, drugs for hemorrhoid disease and other prescription drugs, as well as over-the-counter (OTC) drugs. The Company distributes its products within domestic market and to overseas markets. On August 22, 2013, it acquired a certain shares of a Korea-based company, which is mainly engaged in the manufacture of medicine raw materials and development of medical devices. After the transaction, the Company held a 100% stake of the Korea-based company.
DAE HWA PHARMACEUTICAL CO., LTD. 
